Aartech Solonics (542580) Mar 2025 Filing Analysis

The technology moat strengthened from an R&D-led capability in FY2024-25 into a more commercially relevant platform by Q1 FY27. FY2024-25 included a ₹100 crore-plus ultracapacitor sales pipeline, an IIT Bombay/Army-developed AAPM and DRDO-related pilots. The later baseline confirms more than 15 years of ultracapacitor application experience and proprietary products used in railways, defence and missile-related applications. (2 expanding)

CRP was already the largest disclosed business line in FY2025, with revenue above ₹20 crore. By Q1 FY27, it remained the largest segment at ₹224 lakh and 30.8% of revenue. This indicates continued scale leadership, although the available figures are not directly comparable because FY2025 is annual and the baseline is quarterly. (1 expanding, 1 shifted)

Domestic revenue remained overwhelmingly dominant, while exports were a small but growing strategic channel. FY2024-25 export revenue was ₹129.08 lakh, or about 3.6% of operating revenue, versus ₹137.13 lakh or about 4.2% in FY2023-24. Thus exports contracted in absolute value and share during the reported year, although the company added UK, Middle East and Qatar credentials and the later baseline continues to describe international activity as part of the business model. (1 contracting, 2 expanding)

Project activity was an established strategic vertical in FY2024-25, focused on new innovation-led problem statements and defence projects. By Q1 FY27, project businesses generated ₹156 lakh or 21.4% of revenue, making them a substantial contributor. The segment has therefore expanded in materiality, although execution and approval cycles remain long. (1 expanding, 1 shifted, 1 stable)

BTS was a high-margin product line with 20% year-on-year growth in FY2024-25. By Q1 FY27, it generated ₹123 lakh and represented 16.9% of revenue. The business remains meaningful but its share is now below CRP, trading and project businesses, indicating a relative share shift within the portfolio even though the product itself continues to grow. (1 shifted, 1 contracting, 1 expanding)

The FY25 report provides concrete evidence that the apparent opportunity pipeline was not yet equivalent to secured revenue. Faradigm had an active sales pipeline of over ₹100 crore, but the report describes these as opportunities and does not disclose confirmed orders or conversion rates. This supports a HIGH risk of uncertain near-term revenue visibility. No later baseline comparison is available in this document. (2 insufficient_data, 2 stable, 1 intensifying)

Employee benefit expense increased from ₹4.16 crore to ₹4.55 crore standalone, an increase of about 9.4%, while the permanent workforce declined from 79 to 69 employees. Management also reports 20.27% attrition, above its stated 10–12% benchmark, and specialised talent shortages. This makes the cost and retention risk material, but the company reported operating-margin improvement in key lines. Overall severity is MEDIUM rather than HIGH. (1 intensifying, 1 stable, 1 insufficient_data)

The FY25 report confirms that CRP growth is currently based on SCADA-compatible panels and entry into new states, but it does not disclose successful commercial entry into the higher-voltage range described in the later baseline. This document therefore establishes the earlier risk of technology-scaling and certification dependence, but does not support a direction-of-change assessment. (1 insufficient_data)